Arvinas (ARVN) Preferred Dividend Payments (2017 - 2018)
Arvinas (ARVN) posted quarterly Preferred Dividend Payments of $112.1 million for Q3 2018, up 655.36% quarter-over-quarter from $14.8 million in Q2 2018.
Powered by 
Analysis
Arvinas (ARVN) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
Arvinas' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $112.1 million for Q3 2018.
- In Q3 2018, Preferred Dividend Payments changed N/A year-over-year to $112.1 million; the TTM figure through Sep 2019 stood at $112.1 million (down 44.79% YoY), while the FY2018 annual figure was $198.4 million, up 4240.22% from the prior year.
- Preferred Dividend Payments for Q3 2018 stood at $112.1 million, up from $14.8 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $112.1 million in Q3 2018, with the low at $4.6 million in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Arvinas | 605.88 Mn | 37.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 112.05 Mn |
| Jun 30, 2018 | 14.83 Mn |
| Mar 31, 2018 | 71.48 Mn |
| Dec 31, 2017 | 4.57 Mn |